These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 118957)

  • 61. In vitro antimicrobial activity of propolis and synergism between propolis and antimicrobial drugs.
    Stepanović S; Antić N; Dakić I; Svabić-Vlahović M
    Microbiol Res; 2003; 158(4):353-7. PubMed ID: 14717457
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro synergy of cefazolin-tobramycin against gram-positive bacteria.
    Collins RF; Edwards LD
    J Antimicrob Chemother; 1980 May; 6(3):323-31. PubMed ID: 7400067
    [No Abstract]   [Full Text] [Related]  

  • 63. Streptogramins: an answer to antibiotic resistance in gram-positive bacteria.
    Leclercq R; Courvalin P
    Lancet; 1998 Aug; 352(9128):591-2. PubMed ID: 9746015
    [No Abstract]   [Full Text] [Related]  

  • 64. [Combination of antibiotics with analgesic and antipyretic substances (author's transl)].
    Pasăre G; Pasăre V; Eftimescu N; Ivan M; Milici A
    Zentralbl Bakteriol Naturwiss; 1979; 134(7):640-7. PubMed ID: 398650
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanism of action of streptogramins and macrolides.
    Vannuffel P; Cocito C
    Drugs; 1996; 51 Suppl 1():20-30. PubMed ID: 8724813
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A convenient solid-phase strategy for the synthesis of antimicrobial cyclic lipopeptides.
    Vilà S; Badosa E; Montesinos E; Feliu L; Planas M
    Org Biomol Chem; 2013 May; 11(20):3365-74. PubMed ID: 23563492
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interactions of antimicrobial agents and antineoplastic agents.
    Yamashiro Y; Fukuoka Y; Yotsuji A; Yasuda T; Saikawa I; Ueda Y
    J Antimicrob Chemother; 1986 Dec; 18(6):703-8. PubMed ID: 3102447
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ferrocins, new iron-containing peptide antibiotics produced by bacteria. Taxonomy, fermentation and biological activity.
    Katayama N; Nozaki Y; Okonogi K; Harada S; Ono H
    J Antibiot (Tokyo); 1993 Jan; 46(1):65-70. PubMed ID: 8436561
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metabolism of macromolecules in bacteria treated with virginiamycin.
    Cocito C
    J Gen Microbiol; 1969 Aug; 57(2):179-94. PubMed ID: 4981916
    [No Abstract]   [Full Text] [Related]  

  • 70. An alternative strategy for combination therapy: Interactions between polymyxin B and non-antibiotics.
    Otto RG; van Gorp E; Kloezen W; Meletiadis J; van den Berg S; Mouton JW
    Int J Antimicrob Agents; 2019 Jan; 53(1):34-39. PubMed ID: 30240838
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preparation and properties of derivatives of virginiamycin S.
    Janssen G; Anne J; Vanderhaeghe H
    J Antibiot (Tokyo); 1977 Feb; 30(2):141-5. PubMed ID: 403168
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Synergy and duality in peptide antibiotic mechanisms.
    McCafferty DG; Cudic P; Yu MK; Behenna DC; Kruger R
    Curr Opin Chem Biol; 1999 Dec; 3(6):672-80. PubMed ID: 10600730
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effect of zinc bacitracin on the susceptibility of selected gram negative and gram positive bacteria to therapeutic antibiotics.
    Walton JR
    Zentralbl Veterinarmed B; 1978 May; 25(4):329-31. PubMed ID: 696077
    [No Abstract]   [Full Text] [Related]  

  • 74. Aspiculamycin, a new cytosine nucleoside antibiotic. 3. Biological activities, in vitro and in vivo.
    Haneishi T; Arai M; Kitano N; Yamamoto S
    J Antibiot (Tokyo); 1974 May; 27(5):339-42. PubMed ID: 4850656
    [No Abstract]   [Full Text] [Related]  

  • 75. Studies on antibiotic synergism and antagonism. Synergism among seven antibiotics against various bacteria in vitro.
    JEWETZ E; GUNNISON JB; BRUFF JB; COLEMAN VR
    J Bacteriol; 1952 Jul; 64(1):29-39. PubMed ID: 14946096
    [No Abstract]   [Full Text] [Related]  

  • 76. Studies on mikamycin B lactonase. V. Metabolic control in mikamycin B fermentation.
    Kim CH; Endo T; Yonehara H
    J Antibiot (Tokyo); 1988 Jan; 41(1):73-80. PubMed ID: 3126170
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of a synergistic combination between the non-antibiotic microbicides diclofenac and trifluoperazine.
    Dastidar SG; Annadurai S; Kumar KA; Dutta NK; Chakrabarty AN
    Int J Antimicrob Agents; 2003 Jun; 21(6):599-601. PubMed ID: 12791481
    [No Abstract]   [Full Text] [Related]  

  • 78. Occurrence of D-amino acids in natural products.
    Armstrong DW; Berthod A
    Nat Prod Bioprospect; 2023 Nov; 13(1):47. PubMed ID: 37932633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Controlled biosynthesis of neoviridogriseins, new homologues of viridogrisein. IV. In vitro synergism between neoviridogrisein II and the antibiotics of the mikamycin A group.
    Okumura Y; Sakamoto M; Takei T; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1979 Nov; 32(11):1130-6. PubMed ID: 118957
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Controlled biosynthesis of neoviridogriseins, new homologues of viridogrisein II. Production, biological properties and structure of neoviridogrisein II.
    Okumura Y; Takei T; Sakamoto M; Ishikura T; Fukagawa Y
    J Antibiot (Tokyo); 1979 Jun; 32(6):584-92. PubMed ID: 468734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.